Saturday - January 17, 2026

Category Archives: Business

HER2-Negative Metastatic Breast Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai

The Key HER2-Negative Metastatic Breast Cancer Companies in the market include – Genentech, Inc., AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai Inc., Novartis Pharmaceuticals, Adagene Inc, Jiangsu HengRui Medicine Co., Ltd, Pfizer, Novartis, CytomX Therapeutics, Tyme, Inc, … Continue reading →

Knee Osteoarthritis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observe | Sanofi, Anterogen, Enlivex Therapeutics, ICM, Peptinov, Techfields Pharma, Paradigm Biopharma

The Key Knee Osteoarthritis Companies in the market include – Sanofi, Anterogen, Enlivex Therapeutics, ICM, Sao Thai Duong Joint Stock Company, Peptinov, Techfields Pharma, Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutic, Noven Pharmaceuticals, Kolon TissueGene, Paradigm Biopharmaceuticals, Organogenesis, BioSenic (Bone … Continue reading →

Graves Ophthalmopathy Market Growth to Surge During Forecast Period (2024–2034), Says DelveInsight | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited

The Key Graves Ophthalmopathy Companies in the market include – Immunovant Sciences GmbH, Horizon Pharma USA, Inc., Viridian Therapeutics, Inc., Tourmaline Bio, Inc., ACELYRIN Inc., Hoffmann-La Roche, Horizon Therapeutics USA, Inc., Lassen Therapeutics Inc., Novartis, Sling Therapeutics, Inc., Lassen Therapeutics, … Continue reading →

Neurotrophic Keratitis Market to Witness Promising Upswing by 2034, DelveInsight Forecasts | Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotech

The Key Neurotrophic Keratitis Companies in the market include – Dompé Farmaceutici, BRIM Biotechnology, ReGenTree, LLC, Oyster Point Pharma, Inc., Syneos Health, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, and others.   DelveInsight’s “Neurotrophic Keratitis Market Insights, Epidemiology, and Market Forecast-2034″ … Continue reading →

Metastatic Prostate Cancer Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Merck, Arvinas Androgen Receptor, UNICANCER, Aragon Pharma, Mark Stein, Novartis

The Key Metastatic Prostate Cancer Companies in the market include – Curium US LLC, Bayer, Hookipa Biotech GmbH, University Health Network, Merck Sharp & Dohme, Arvinas Androgen Receptor, UNICANCER, Aragon Pharmaceuticals, Mark Stein, Novartis, Orion Corporation, Janssen Research & Development, … Continue reading →

Prostate Cancer Pipeline and Competitive Landscape: 150+ Companies, 160+ Therapies, and the Next Wave of FDA-Backed Innovation, analyses DelveInsight

Prostate Cancer Pipeline Leading organizations including Curium, Merck, Telix Pharmaceuticals, Exelixis, AstraZeneca, AB Science, Lantheus, Pfizer, Jiangsu Hengrui Pharmaceuticals, Modra Pharmaceuticals, Bristol-Myers Squibb, Zenith Epigenetics, Xencor, Merus, Phosplatin Therapeutics, Laekna Therapeutics, Tavanta Therapeutics, Madison Vaccines, Taiho Pharmaceutical, Ipsen Biopharmaceuticals, LAVA … Continue reading →

Neuroblastoma Market Size and Forecast (2025–2034): 7 Major Markets, 700-800 US Annual Cases, and 25+ Pipeline Assets | DelveInsight

Neuroblastoma Market Major players active in the neuroblastoma treatment space include United Therapeutics, EUSA Pharma, Y-mAbs Therapeutics, Clarity Pharmaceuticals, along with several other companies. The Neuroblastoma Treatment Market is expected to witness substantial growth through 2034. Nearly 90% of neuroblastoma … Continue reading →

5G Services Market Global Growth, Key Opportunities, Latest Trends, Top Companies, Recent Developments and Future Scope

China Mobile (China), Verizon Communications (US), Deutsche Telekom AG (Germany), Vodafone Group (UK), SK Telecom (South Korea), BT Group (UK), China Telecom (China), Orange (France), KT Corporation (South Korea), China Unicom (China), Telstra Group (Australia). 5G Services Market Size, Share, … Continue reading →